Cargando…

Different primers for diagnosing circulating cell-free DNA of colorectal cancer

BACKGROUND: Cell-free DNA (cfDNA) primers have been designed to screen for cancer diagnosis, but the results have been inconsistent. The study aimed to compare different primers for diagnosing cfDNA of colorectal cancer (CRC). METHODS: Peripheral blood specimens were collected from 71 patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Hao, Li, Qigang, Liao, Juan, Bai, Lian, Wu, Shuai, Xie, Jian, He, Gan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798792/ https://www.ncbi.nlm.nih.gov/pubmed/35117709 http://dx.doi.org/10.21037/tcr-19-2017

Ejemplares similares

Blood free-circulating DNA testing by highly sensitive methylation assay to diagnose colorectal neoplasias
por: Suehiro, Yutaka, et al.
Publicado: (2018)

Circulating cell-free DNA use for diagnosing cholangiocarcinoma
por: Sorscher, Steven
Publicado: (2019)

Role of circulating free DNA in colorectal cancer
por: Matikas, Alexios, et al.
Publicado: (2016)

Molecular Alterations in Circulating Cell-Free DNA in Patients with Colorectal Adenoma or Carcinoma
por: Hu, Ying, et al.
Publicado: (2020)

Circulating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer
por: Hao, T B, et al.
Publicado: (2014)

The Prognostic Value of Circulating Cell-Free DNA in Colorectal Cancer: A Meta-Analysis
por: Basnet, Shiva, et al.
Publicado: (2016)

Circulating Cell-Free DNA and Colorectal Cancer: A Systematic Review
por: Vymetalkova, Veronika, et al.
Publicado: (2018)

Clinical utility of circulating cell-free DNA in advanced colorectal cancer
por: Pereira, Allan A. Lima, et al.
Publicado: (2017)

Predicting disease-free survival in colorectal cancer by circulating tumor DNA methylation markers
por: Yang, Xin, et al.
Publicado: (2022)

The diagnostic accuracy of circulating free DNA for the detection of KRAS mutation status in colorectal cancer: A meta‐analysis
por: Xie, Wenli, et al.
Publicado: (2019)

Circulating cell-free methylated DNA and lactate dehydrogenase release in colorectal cancer
por: Philipp, Alexander B, et al.
Publicado: (2014)

Circulating Free DNA as Biomarker and Source for Mutation Detection in Metastatic Colorectal Cancer
por: Spindler, Karen Lise Garm, et al.
Publicado: (2015)

Cell-free DNA and circulating TERT promoter mutation for disease monitoring in newly-diagnosed glioblastoma
por: Fontanilles, Maxime, et al.
Publicado: (2020)

Circulating Cell-Free DNA or Circulating Tumor DNA in the Management of Ovarian and Endometrial Cancer
por: Chen, Qian, et al.
Publicado: (2019)

Circulating cell free DNA as the diagnostic marker for colorectal cancer: a systematic review and meta-analysis
por: Wang, Xin, et al.
Publicado: (2018)

Detection of mutations in circulating cell‐free DNA in relation to disease stage in colorectal cancer
por: Liebs, Sandra, et al.
Publicado: (2019)

Blood Free-Circulating DNA Testing of Methylated RUNX3 Is Useful for Diagnosing Early Gastric Cancer
por: Hideura, Eizaburou, et al.
Publicado: (2020)

Analysis of colorectal cancer‐related mutations by liquid biopsy: Utility of circulating cell‐free DNA and circulating tumor cells
por: Takeda, Kohki, et al.
Publicado: (2019)

Circulating tumor cells (CTC) and KRAS mutant circulating free DNA (cfDNA) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer
por: Earl, Julie, et al.
Publicado: (2015)

Imaging and histopathologic correlates of plasma cell-free DNA concentration and circulating tumor DNA in adult patients with newly diagnosed glioblastoma
por: Nabavizadeh, Seyed Ali, et al.
Publicado: (2020)

Tumour pharmacodynamics and circulating cell free DNA in patients with refractory colorectal carcinoma treated with regorafenib
por: Wong, Andrea Li Ann, et al.
Publicado: (2015)

Genome-wide discovery of circulating cell-free DNA methylation biomarkers for colorectal cancer detection
por: Fang, Qingxiao, et al.
Publicado: (2023)

Using Circulating Tumor DNA as a Novel Biomarker to Screen and Diagnose Colorectal Cancer: A Meta-Analysis
por: Min, Liang, et al.
Publicado: (2023)

Abnormal DNA methylation as a cell-free circulating DNA biomarker for colorectal cancer detection: A review of literature
por: Galanopoulos, Michail, et al.
Publicado: (2017)

LINE-1 hypomethylation status of circulating cell-free DNA in plasma as a biomarker for colorectal cancer
por: Nagai, Yuzo, et al.
Publicado: (2017)

Treatment monitoring in metastatic colorectal cancer patients by quantification and KRAS genotyping of circulating cell-free DNA
por: Berger, Andreas W., et al.
Publicado: (2017)

Utility of KRAS mutation detection using circulating cell‐free DNA from patients with colorectal cancer
por: Yamada, Takeshi, et al.
Publicado: (2016)

The Specific Gravity-Free Method for the Isolation of Circulating Tumor KRAS Mutant DNA and Exosome in Colorectal Cancer
por: Lee, Tae Hee, et al.
Publicado: (2021)

Analyzing microsatellite instability and gene mutation in circulating cell-free DNA to monitor colorectal cancer progression
por: Fu, Yun, et al.
Publicado: (2021)

Identification of a 5-Hydroxymethylation Signature in Circulating Cell-Free DNA for the Noninvasive Detection of Colorectal Cancer
por: Liu, Hongwei, et al.
Publicado: (2022)

Prognostic significance of sarcopenia diagnosed based on the anthropometric equation for progression-free survival and overall survival in patients with colorectal cancer
por: Xie, Hailun, et al.
Publicado: (2023)

Cell-free circulating tumor DNA in cancer
por: Qin, Zhen, et al.
Publicado: (2016)

Quantifying circulating cell-free DNA in humans
por: Meddeb, Romain, et al.
Publicado: (2019)

Life and death of circulating cell-free DNA
por: Kustanovich, Anatoli, et al.
Publicado: (2019)

Circulating tumour DNA in colorectal cancer management
por: Cohen, Ryan, et al.
Publicado: (2023)

Loss of Rose Fragrance under Chilling Stress Is Associated with Changes in DNA Methylation and Volatile Biosynthesis
por: Xie, Limei, et al.
Publicado: (2023)

Circulating Glycan Monosaccharide Composite-Based Biomarker Diagnoses Colorectal Cancer at Early Stages and Predicts Prognosis
por: Li, Haoran, et al.
Publicado: (2022)

Tissue-specific cell-free DNA degradation quantifies circulating tumor DNA burden
por: Zhu, Guanhua, et al.
Publicado: (2021)

Detection of KRAS mutant alleles in circulating cell-free tumor DNA in colorectal cancer patients resistant to cetuximab
por: Del Re, Marzia, et al.
Publicado: (2014)

Circulating Cell Free DNA Integrity Index as a Biomarker for Response to Chemotherapy in Patients with Metastatic Colorectal Carcinoma
por: Eskander, Nancy Samir, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mn7vavvo7lk0c4hreke51834bh